1,3- dimethyl- 1,2,3,4- tetrahydroisoquinoline

RN given refers to parent cpd

Also Known As:

1,3-DiMeTIQ; 1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, (1S-cis)-isomer; 1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline, (1R-cis)-isomer; 1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline, (1R-trans)-isomer; 1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline, (1S-trans)-isomer

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoquinolines: 34
      - Tetrahydroisoquinolines: 44
        1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline: 1

Experts

1.	Abe, Kenji: 1 article (03/2010)
2.	Chida, Satomi: 1 article (03/2010)
3.	Horiguchi, Yoshie: 1 article (03/2010)
4.	Hoshi, Keiko: 1 article (03/2010)
5.	Katagiri, Nobuyuki: 1 article (03/2010)
6.	Kitabatake, Michikazu: 1 article (03/2010)
7.	Nojima, Hiroshi: 1 article (03/2010)
8.	Taguchi, Kyoji: 1 article (03/2010)

Related Diseases

1.	Hypokinesia (Bradykinesia) 03/19/2010 - "Repeated administration of MPTP induced bradykinesia, a symptom of behavioral abnormality; this was prevented by both 1,3-diMeTIQ and 1,3-diMe-N-proTIQ pretreatments. "

Related Drugs and Biologics

1.	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)